CN Stock MarketDetailed Quotes

000739 Apeloa Pharmaceutical

Watchlist
  • 16.27
  • -0.37-2.22%
Market Closed Dec 13 15:00 CST
19.02BMarket Cap17.72P/E (TTM)

Apeloa Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
9.30%9.29B
7.96%6.43B
3.65%3.2B
8.81%11.47B
12.57%8.5B
19.43%5.95B
46.83%3.09B
17.92%10.54B
18.00%7.55B
16.57%4.99B
Operating revenue
9.30%9.29B
7.96%6.43B
3.65%3.2B
8.81%11.47B
12.57%8.5B
19.43%5.95B
46.83%3.09B
17.92%10.54B
18.00%7.55B
16.57%4.99B
Other operating revenue
----
-52.92%17.2M
----
-13.25%33.92M
----
25.59%36.53M
----
20.53%39.1M
----
72.32%29.09M
Total operating cost
11.42%8.3B
8.85%5.65B
4.95%2.86B
8.05%10.23B
10.46%7.44B
16.33%5.19B
40.84%2.73B
19.50%9.47B
20.66%6.74B
21.42%4.46B
Operating cost
13.10%7.04B
10.76%4.84B
9.28%2.43B
6.30%8.53B
9.27%6.22B
17.31%4.37B
44.80%2.22B
22.46%8.02B
24.76%5.7B
25.11%3.73B
Operating tax surcharges
2.83%38.46M
3.02%27.69M
-37.96%8.36M
76.59%56.09M
47.66%37.4M
58.92%26.88M
41.95%13.48M
-3.89%31.76M
-14.28%25.33M
-19.98%16.91M
Operating expense
-7.00%399.85M
4.85%280.58M
13.20%152.63M
23.01%658.42M
8.85%429.93M
1.88%267.59M
7.61%134.83M
18.28%535.26M
5.10%394.99M
0.19%262.65M
Administration expense
1.81%364.41M
-4.07%234.37M
-9.89%123.25M
3.66%466.55M
4.02%357.91M
7.53%244.33M
17.51%136.78M
-0.85%450.06M
11.40%344.07M
16.46%227.22M
Financial expense
84.07%-14.05M
32.69%-46.54M
-120.80%-3.62M
1.30%-104.37M
29.66%-88.19M
-34.29%-69.14M
114.16%17.41M
-639.71%-105.75M
-732.30%-125.38M
-463.36%-51.48M
-Interest expense (Financial expense)
-17.65%22.66M
-10.32%15.43M
-1.51%8.42M
17.08%34.23M
31.29%27.51M
28.82%17.21M
72.27%8.55M
79.17%29.24M
97.18%20.96M
127.67%13.36M
-Interest Income (Financial expense)
8.58%-61.73M
-18.72%-38.72M
-10.63%-10.98M
-49.63%-113.47M
-38.51%-67.53M
-9.39%-32.62M
25.80%-9.92M
-0.65%-75.83M
6.28%-48.75M
-178.46%-29.82M
Research and development
-3.42%467.2M
-10.52%314.77M
-24.38%152.94M
17.25%624.87M
19.44%483.76M
24.59%351.79M
42.14%202.24M
19.43%532.92M
25.98%405.01M
37.43%282.36M
Credit Impairment Loss
84.56%4.48M
-123.94%-23.46M
-21.02%-23.59M
44.30%-14.65M
123.30%2.43M
43.99%-10.47M
-2,229.53%-19.49M
-22.35%-26.31M
48.99%-10.43M
-55.55%-18.7M
Asset Impairment Loss
-6.51%-64.06M
-92.21%-69.04M
25.82%-30.04M
-79.51%-91.83M
-1,279.62%-60.14M
-799.51%-35.92M
-24,708.33%-40.5M
-93.87%-51.16M
-146.57%-4.36M
-695.25%-3.99M
Other net revenue
166.64%27.97M
31.69%-36.5M
43.19%-35.08M
64.49%-23.01M
7.54%-41.97M
-323.80%-53.43M
-496.29%-61.76M
-164.52%-64.79M
-150.58%-45.39M
-126.40%-12.61M
Fair value change income
135.88%8.47M
81.20%-2.54M
-167.57%-2.83M
99.92%-19.23K
70.01%-23.6M
71.60%-13.49M
203.72%4.19M
3.30%-22.84M
-266.32%-78.71M
-183.42%-47.49M
Invest income
-122.64%-8.13M
8.19%-723.42K
72.84%-2.02M
63.72%-21.68M
85.59%-3.65M
-126.14%-787.93K
-178.55%-7.43M
-166.15%-59.77M
-144.40%-25.35M
-92.80%3.01M
-Including: Investment income associates
450.12%2.06M
33.43%602.32K
59.17%-1.77M
-21.48%3.27M
-80.57%374.18K
-70.00%451.4K
-451.58%-4.33M
-67.68%4.16M
147.79%1.93M
126.81%1.5M
Asset deal income
3,822.25%940.32K
8,654.70%567.33K
--278.04K
-3.18%1.33M
-93.99%23.97K
-96.30%6.48K
----
390.75%1.37M
-76.94%399.07K
-58.74%174.91K
Other revenue
100.75%86.27M
712.04%58.68M
1,466.73%23.12M
10.59%103.85M
-41.17%42.98M
-86.71%7.23M
-84.02%1.48M
15.52%93.91M
-2.08%73.06M
61.91%54.39M
Operating profit
0.95%1.02B
4.45%740.44M
1.38%300.3M
20.61%1.22B
32.35%1.01B
39.07%708.93M
64.24%296.2M
-9.62%1.01B
-15.20%765.81M
-21.44%509.77M
Add:Non operating Income
-29.28%1.53M
-29.53%910.43K
65.01%480.65K
-76.02%1.42M
-55.44%2.17M
-61.68%1.29M
-88.13%291.28K
62.86%5.94M
431.20%4.87M
317.97%3.37M
Less:Non operating expense
-56.25%4.81M
-0.56%2.85M
-33.24%1.29M
207.91%16.92M
133.38%11M
-22.40%2.87M
111.63%1.93M
-38.40%5.5M
6.10%4.71M
53.92%3.69M
Total profit
1.51%1.02B
4.40%738.5M
1.67%299.49M
19.03%1.2B
31.17%1B
38.85%707.36M
61.95%294.56M
-9.16%1.01B
-14.85%765.96M
-21.30%509.45M
Less:Income tax cost
-1.91%150.46M
7.10%113.86M
0.94%55.78M
552.29%149.34M
40.88%153.38M
46.71%106.31M
85.44%55.26M
-85.56%22.89M
-20.77%108.87M
-22.82%72.46M
Net profit
2.12%869.39M
3.93%624.65M
1.84%243.71M
6.69%1.06B
29.56%851.31M
37.54%601.04M
57.34%239.31M
3.52%989.17M
-13.78%657.09M
-21.04%436.98M
Net profit from continuing operation
2.12%869.39M
3.93%624.65M
1.84%243.71M
6.69%1.06B
29.56%851.31M
37.54%601.04M
57.34%239.31M
3.52%989.17M
-13.78%657.09M
-21.04%436.98M
Less:Minority Profit
-793.17%-264.29K
-832.16%-197.72K
-19.22%-2.29K
-1,093.06%-33.84K
84.14%-29.59K
---21.21K
---1.92K
---2.84K
---186.53K
----
Net profit of parent company owners
2.15%869.65M
3.96%624.84M
1.84%243.72M
6.69%1.06B
29.53%851.34M
37.55%601.07M
57.35%239.31M
3.52%989.17M
-13.76%657.28M
-21.04%436.98M
Earning per share
Basic earning per share
2.54%0.7466
4.09%0.535
1.81%0.2084
7.12%0.9025
30.16%0.7281
38.51%0.514
58.56%0.2047
3.91%0.8425
-13.50%0.5594
-20.98%0.3711
Diluted earning per share
2.54%0.7466
4.09%0.535
1.81%0.2084
7.12%0.9025
30.16%0.7281
38.51%0.514
58.56%0.2047
3.91%0.8425
-13.50%0.5594
-20.98%0.3711
Other composite income
215.37%3.57M
128.29%874.3K
152.70%743.15K
329.58%2.8M
-125.97%-3.1M
-485.81%-3.09M
1,890.26%294.09K
-855.83%-1.22M
-3,711.78%-1.37M
-1,316.69%-527.64K
Other composite income of parent company owners
215.37%3.57M
128.29%874.3K
152.70%743.15K
329.58%2.8M
-125.97%-3.1M
-485.81%-3.09M
1,890.26%294.09K
-855.83%-1.22M
-3,711.78%-1.37M
-1,316.69%-527.64K
Total composite income
2.92%872.96M
4.61%625.52M
2.03%244.46M
7.10%1.06B
29.36%848.22M
37.00%597.95M
57.52%239.6M
3.37%987.95M
-13.97%655.72M
-21.14%436.46M
Total composite income of parent company owners
2.94%873.22M
4.64%625.72M
2.03%244.46M
7.10%1.06B
29.32%848.25M
37.01%597.97M
57.52%239.6M
3.37%987.95M
-13.94%655.91M
-21.14%436.46M
Total composite income of minority owners
-793.17%-264.29K
-832.16%-197.72K
-19.22%-2.29K
-1,093.06%-33.84K
84.14%-29.59K
---21.21K
---1.92K
---2.84K
---186.53K
----
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Hexin Certified Public Accountants (Special General Partnership)
--
--
--
Hexin Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue 9.30%9.29B7.96%6.43B3.65%3.2B8.81%11.47B12.57%8.5B19.43%5.95B46.83%3.09B17.92%10.54B18.00%7.55B16.57%4.99B
Operating revenue 9.30%9.29B7.96%6.43B3.65%3.2B8.81%11.47B12.57%8.5B19.43%5.95B46.83%3.09B17.92%10.54B18.00%7.55B16.57%4.99B
Other operating revenue -----52.92%17.2M-----13.25%33.92M----25.59%36.53M----20.53%39.1M----72.32%29.09M
Total operating cost 11.42%8.3B8.85%5.65B4.95%2.86B8.05%10.23B10.46%7.44B16.33%5.19B40.84%2.73B19.50%9.47B20.66%6.74B21.42%4.46B
Operating cost 13.10%7.04B10.76%4.84B9.28%2.43B6.30%8.53B9.27%6.22B17.31%4.37B44.80%2.22B22.46%8.02B24.76%5.7B25.11%3.73B
Operating tax surcharges 2.83%38.46M3.02%27.69M-37.96%8.36M76.59%56.09M47.66%37.4M58.92%26.88M41.95%13.48M-3.89%31.76M-14.28%25.33M-19.98%16.91M
Operating expense -7.00%399.85M4.85%280.58M13.20%152.63M23.01%658.42M8.85%429.93M1.88%267.59M7.61%134.83M18.28%535.26M5.10%394.99M0.19%262.65M
Administration expense 1.81%364.41M-4.07%234.37M-9.89%123.25M3.66%466.55M4.02%357.91M7.53%244.33M17.51%136.78M-0.85%450.06M11.40%344.07M16.46%227.22M
Financial expense 84.07%-14.05M32.69%-46.54M-120.80%-3.62M1.30%-104.37M29.66%-88.19M-34.29%-69.14M114.16%17.41M-639.71%-105.75M-732.30%-125.38M-463.36%-51.48M
-Interest expense (Financial expense) -17.65%22.66M-10.32%15.43M-1.51%8.42M17.08%34.23M31.29%27.51M28.82%17.21M72.27%8.55M79.17%29.24M97.18%20.96M127.67%13.36M
-Interest Income (Financial expense) 8.58%-61.73M-18.72%-38.72M-10.63%-10.98M-49.63%-113.47M-38.51%-67.53M-9.39%-32.62M25.80%-9.92M-0.65%-75.83M6.28%-48.75M-178.46%-29.82M
Research and development -3.42%467.2M-10.52%314.77M-24.38%152.94M17.25%624.87M19.44%483.76M24.59%351.79M42.14%202.24M19.43%532.92M25.98%405.01M37.43%282.36M
Credit Impairment Loss 84.56%4.48M-123.94%-23.46M-21.02%-23.59M44.30%-14.65M123.30%2.43M43.99%-10.47M-2,229.53%-19.49M-22.35%-26.31M48.99%-10.43M-55.55%-18.7M
Asset Impairment Loss -6.51%-64.06M-92.21%-69.04M25.82%-30.04M-79.51%-91.83M-1,279.62%-60.14M-799.51%-35.92M-24,708.33%-40.5M-93.87%-51.16M-146.57%-4.36M-695.25%-3.99M
Other net revenue 166.64%27.97M31.69%-36.5M43.19%-35.08M64.49%-23.01M7.54%-41.97M-323.80%-53.43M-496.29%-61.76M-164.52%-64.79M-150.58%-45.39M-126.40%-12.61M
Fair value change income 135.88%8.47M81.20%-2.54M-167.57%-2.83M99.92%-19.23K70.01%-23.6M71.60%-13.49M203.72%4.19M3.30%-22.84M-266.32%-78.71M-183.42%-47.49M
Invest income -122.64%-8.13M8.19%-723.42K72.84%-2.02M63.72%-21.68M85.59%-3.65M-126.14%-787.93K-178.55%-7.43M-166.15%-59.77M-144.40%-25.35M-92.80%3.01M
-Including: Investment income associates 450.12%2.06M33.43%602.32K59.17%-1.77M-21.48%3.27M-80.57%374.18K-70.00%451.4K-451.58%-4.33M-67.68%4.16M147.79%1.93M126.81%1.5M
Asset deal income 3,822.25%940.32K8,654.70%567.33K--278.04K-3.18%1.33M-93.99%23.97K-96.30%6.48K----390.75%1.37M-76.94%399.07K-58.74%174.91K
Other revenue 100.75%86.27M712.04%58.68M1,466.73%23.12M10.59%103.85M-41.17%42.98M-86.71%7.23M-84.02%1.48M15.52%93.91M-2.08%73.06M61.91%54.39M
Operating profit 0.95%1.02B4.45%740.44M1.38%300.3M20.61%1.22B32.35%1.01B39.07%708.93M64.24%296.2M-9.62%1.01B-15.20%765.81M-21.44%509.77M
Add:Non operating Income -29.28%1.53M-29.53%910.43K65.01%480.65K-76.02%1.42M-55.44%2.17M-61.68%1.29M-88.13%291.28K62.86%5.94M431.20%4.87M317.97%3.37M
Less:Non operating expense -56.25%4.81M-0.56%2.85M-33.24%1.29M207.91%16.92M133.38%11M-22.40%2.87M111.63%1.93M-38.40%5.5M6.10%4.71M53.92%3.69M
Total profit 1.51%1.02B4.40%738.5M1.67%299.49M19.03%1.2B31.17%1B38.85%707.36M61.95%294.56M-9.16%1.01B-14.85%765.96M-21.30%509.45M
Less:Income tax cost -1.91%150.46M7.10%113.86M0.94%55.78M552.29%149.34M40.88%153.38M46.71%106.31M85.44%55.26M-85.56%22.89M-20.77%108.87M-22.82%72.46M
Net profit 2.12%869.39M3.93%624.65M1.84%243.71M6.69%1.06B29.56%851.31M37.54%601.04M57.34%239.31M3.52%989.17M-13.78%657.09M-21.04%436.98M
Net profit from continuing operation 2.12%869.39M3.93%624.65M1.84%243.71M6.69%1.06B29.56%851.31M37.54%601.04M57.34%239.31M3.52%989.17M-13.78%657.09M-21.04%436.98M
Less:Minority Profit -793.17%-264.29K-832.16%-197.72K-19.22%-2.29K-1,093.06%-33.84K84.14%-29.59K---21.21K---1.92K---2.84K---186.53K----
Net profit of parent company owners 2.15%869.65M3.96%624.84M1.84%243.72M6.69%1.06B29.53%851.34M37.55%601.07M57.35%239.31M3.52%989.17M-13.76%657.28M-21.04%436.98M
Earning per share
Basic earning per share 2.54%0.74664.09%0.5351.81%0.20847.12%0.902530.16%0.728138.51%0.51458.56%0.20473.91%0.8425-13.50%0.5594-20.98%0.3711
Diluted earning per share 2.54%0.74664.09%0.5351.81%0.20847.12%0.902530.16%0.728138.51%0.51458.56%0.20473.91%0.8425-13.50%0.5594-20.98%0.3711
Other composite income 215.37%3.57M128.29%874.3K152.70%743.15K329.58%2.8M-125.97%-3.1M-485.81%-3.09M1,890.26%294.09K-855.83%-1.22M-3,711.78%-1.37M-1,316.69%-527.64K
Other composite income of parent company owners 215.37%3.57M128.29%874.3K152.70%743.15K329.58%2.8M-125.97%-3.1M-485.81%-3.09M1,890.26%294.09K-855.83%-1.22M-3,711.78%-1.37M-1,316.69%-527.64K
Total composite income 2.92%872.96M4.61%625.52M2.03%244.46M7.10%1.06B29.36%848.22M37.00%597.95M57.52%239.6M3.37%987.95M-13.97%655.72M-21.14%436.46M
Total composite income of parent company owners 2.94%873.22M4.64%625.72M2.03%244.46M7.10%1.06B29.32%848.25M37.01%597.97M57.52%239.6M3.37%987.95M-13.94%655.91M-21.14%436.46M
Total composite income of minority owners -793.17%-264.29K-832.16%-197.72K-19.22%-2.29K-1,093.06%-33.84K84.14%-29.59K---21.21K---1.92K---2.84K---186.53K----
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Hexin Certified Public Accountants (Special General Partnership)------Hexin Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme Pension Holdings
Pension Holdings
Intraday-1.66%
Superfungus
Superfungus
Intraday-1.74%